Trove
Sign In Sign Up

Michael Cella

Person
Mentions
186
Relationships
12
Events
1
Documents
89
Search

Relationship Network

Loading... nodes
Interactive Network: Click nodes or edges to highlight connections and view details with action buttons. Drag nodes to reposition. Node size indicates connection count. Line color shows relationship strength: red (8-10), orange (6-7), yellow (4-5), gray (weak). Use legend and help buttons in the graph for more guidance.

Event Timeline

Interactive Timeline: Hover over events to see details. Events are arranged chronologically and alternate between top and bottom for better visibility.
12 total relationships
Connected Entity Relationship Type
Strength (mentions)
Documents Actions
person Cowen
Employee
18 Very Strong
38
View
person Cowen
Employment affiliation
11 Very Strong
19
View
person Cowen
Professional
7
3
View
person Cowen
Employment internal distribution
7
2
View
person Cowen
Employment internal
6
2
View
person Cowen
Client
6
1
View
person Cowen
Professional employment
6
2
View
person Cowen
Employment
5
1
View
person Cowen and Company
Employment affiliation
5
1
View
person Cowen and Company, LLC
Employee
5
1
View
person Cowen
Employment recipient
5
1
View
person Cowen and Company
Employee
1
1
View
Date Event Type Description Location Actions
2019-02-25 N/A Publication of Cowen Collaborative Insights report. N/A View

HOUSE_OVERSIGHT_024896.jpg

This document is page 80 of a financial research report produced by Cowen, dated February 25, 2019, analyzing the regulatory landscape for medical cannabis and CBD in Europe. It details the European Parliament's non-binding resolution to harmonize cannabis policies, compares THC limits between the EU (0.2%) and North America (0.3%), and discusses the classification of CBD within the 'Novel Food Catalogue.' The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation.

Financial research report / industry analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024895.jpg

COWEN COLLABORATIVE INSIGHTS February 25, 2019 Global CBD Landscape (Azer) International Drug Conventions (UN) There are three international conv...

Market research report / financial analyst report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024893.jpg

This document is a page from a Cowen 'Collaborative Insights' market report dated February 25, 2019, bearing the Bates stamp HOUSE_OVERSIGHT_024893. It details regulatory crackdowns and guidance regarding CBD (cannabidiol) products in Maine, New York, and North Carolina, specifically noting that these states are aligning with FDA guidance to prohibit CBD in food additives while creating specific frameworks for supplements or topicals. While part of the House Oversight production (likely related to financial records), the text itself discusses cannabis industry regulations and does not mention Jeffrey Epstein or his associates.

Market research report / regulatory update
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024892.jpg

This document is page 76 of a Cowen Collaborative Insights report dated February 25, 2019. It details regulatory challenges and updates regarding CBD and hemp products, specifically focusing on FDA regulations and state-level legislation in California (Assembly Bill 2914). The document bears a 'HOUSE_OVERSIGHT' footer, suggesting it was part of a document production for a congressional investigation, though the content itself is strictly related to cannabis industry regulation and contains no direct mention of Jeffrey Epstein or his associates.

Financial/regulatory research report (cowen collaborative insights); likely part of a house oversight committee document production.
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024891.jpg

This document is a market research report from Cowen Washington Research Group dated February 25, 2019, authored by Assaraf and watermarked for Michael Cella. It analyzes the regulatory landscape for CBD following the passage of the 2018 Farm Bill, specifically highlighting that while hemp was declassified, the FDA (under Commissioner Scott Gottlieb) retains authority over CBD products making health claims or used in food. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was part of a document production for a Congressional investigation.

Market research report / investment brief
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024890.jpg

This document is a page from a Cowen research report discussing the likelihood of Starbucks adopting CBD oil in its beverages. While acknowledging Starbucks as an innovator, the report notes significant regulatory hurdles and operational challenges, concluding that while Starbucks might be the first major player to pilot it eventually, there are no near-term plans.

Financial research report excerpt
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024889.jpg

This document is page 73 of a Cowen financial research report dated February 25, 2019, stamped with a House Oversight Bates number. It details business partnerships in the cannabis/CBD sector, specifically a revenue-sharing agreement between Tilray and Authentic Brands Group (ABG) involving the Nine West brand, and a retail distribution deal between DSW and Green Growth Brands. The document outlines financial terms, including a $100MM-$250MM investment by Tilray, and discusses market expansion opportunities for CBD wellness products.

Financial research report / equity research
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024888.jpg

This document is page 72 of a Cowen Collaborative Insights report dated February 25, 2019, stamped with a House Oversight Bates number. It details a partnership between Authentic Brands Group (ABG) and Tilray focused on CBD wellness products, mentioning brands like Muhammad Ali and Nine West. It also features a diagram regarding Devan Chemical's CBD-infused textile technology.

Market research report / industry insight
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024887.jpg

This document is page 71 of a 'Cowen Collaborative Insights' market research report dated February 25, 2019. The text focuses on the textile industry, specifically analyzing the use of hemp by brands like Patagonia and Nike, and the emerging technology of infusing fabrics with CBD or recovery minerals like Celliant (used by Under Armour). While the document bears a 'HOUSE_OVERSIGHT' Bates stamp, the content itself contains no direct mentions of Jeffrey Epstein, criminal activity, or flight logs; it appears to be part of a larger subpoenaed document cache related to financial or corporate records.

Market research report / investment analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024886.jpg

This document is page 70 of a Cowen market research report dated February 25, 2019, titled 'Collaborative Insights.' It analyzes the growing market for hemp and CBD in the apparel and footwear industries, citing data on the 2014 and 2018 Farm Bills and listing brands like Patagonia and prAna. While the document bears a 'HOUSE_OVERSIGHT' Bates stamp (indicating it was part of a congressional document production, likely related to financial investigations), the text itself contains no direct references to Jeffrey Epstein, Ghislaine Maxwell, or their specific associates.

Market research report / financial analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024885.jpg

A Cowen 'Collaborative Insights' financial research report dated February 25, 2019, authored by Chen. The document analyzes the market entry of Cannabidiol (CBD) into mass retail, predicting that the beauty sector (Luxury and Prestige) will adopt it before broadline retailers like Walmart or Target. It details specific moves by Barneys, Neiman Marcus, DSW, and Sephora. The document bears the Bates stamp HOUSE_OVERSIGHT_024885, indicating it was part of a document production to the House Oversight Committee, likely incidental to a larger financial investigation as no specific Epstein-related individuals are mentioned in the text.

Financial research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024884.jpg

This document is page 68 of a Cowen financial research report dated February 25, 2019, analyzing the potential impact of Amazon and Ebay entering the CBD market. It details Amazon's private label strategy and Ebay's market reach, suggesting both could be significant platforms for the industry. The document bears a House Oversight Committee Bates stamp, indicating it was part of a document production for a congressional investigation.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024882.jpg

This document is page 66 of a Cowen market research report dated February 25, 2019, analyzing U.S. eCommerce trends and CBD adoption. It features charts comparing Prime and Non-Prime purchasing habits on Amazon, specifically regarding personal care products and vitamins. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024882', indicating it was part of a document production to the House Oversight Committee, likely related to investigations involving financial institutions.

Market research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024880.jpg

This document is page 64 of a Cowen Collaborative Insights market research report dated February 25, 2019. It analyzes the healthcare payor and provider perspectives on CBD oils and medical marijuana, specifically discussing reimbursement challenges with CMS and commercial insurers, as well as policy shifts at Intermountain Healthcare in Utah. The document bears a 'HOUSE_OVERSIGHT_024880' Bates stamp, indicating it was part of a document production for a House Oversight Committee investigation.

Market research report / industry analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024879.jpg

This document is page 63 of a Cowen Collaborative Insights report dated February 25, 2019, authored by an analyst named Rhyee. It analyzes the market trends of CBD products in pharmacies, noting that independent pharmacies are adopting CBD sales faster than large chains like CVS or Walgreens due to high margins and demand. The report highlights that while Walgreens (WBA) does not sell CBD in the US, its UK subsidiary, Boots, does sell Dragonfly brand CBD oils, as illustrated by a website screenshot included in the report. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, suggesting it was produced during a congressional investigation.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024878.jpg

This document is page 62 of a Cowen Collaborative Insights report dated February 25, 2019, analyzing the CBD market. It provides detailed profiles of four companies: Mary's Whole Pet/Nutritionals, Mile High Labs, Papa & Barkley, Recess, and Reliva CBD Wellness, discussing their products, funding, and strategies. The document bears a 'HOUSE_OVERSIGHT' footer, indicating it was part of materials reviewed by the House Oversight Committee.

Market research report / investment analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024877.jpg

This document is page 61 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing private companies in the CBD/hemp industry (Botanica, GenCanna, Highline Wellness, Lazarus Naturals, Lord Jones, and Mary's). While stamped 'HOUSE_OVERSIGHT_024877', indicating it is part of a larger document production (likely related to financial oversight), the page content itself is purely market research and contains no direct references to Jeffrey Epstein or his associates. The sidebar indicates the report was intended for Michael Cella at Cowen.

Investment research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024876.jpg

This document is page 60 of a financial research report titled 'Cowen Collaborative Insights' dated February 25, 2019. It analyzes the financial performance and outlook of CBD companies, specifically highlighting Charlotte's Web (CWEB) and CV Sciences (CVSI) for their strong EBITDA margins and revenue growth. The document includes charts comparing various cannabis/CBD companies (TPB, GTI, TLRY, etc.) and projects significant revenue growth for Charlotte's Web through 2020. The document bears a 'HOUSE_OVERSIGHT_024876' stamp, indicating it was part of a document production for a congressional investigation, likely subpoenaed from Cowen regarding financial records.

Financial research report / investment banking analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024875.jpg

This document is page 59 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the Cannabis/CBD market. It presents comparative financial data (Revenue, Gross Profit, and Gross Margin) for several companies including Charlotte's Web, CV Sciences, and Level Brands. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation document production.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024874.jpg

This document is page 58 of a Cowen Collaborative Insights financial report dated February 25, 2019, analyzing the cannabis and CBD industry. It details strategic updates, retail distribution benchmarking (store counts), and revenue figures for companies including TGOD, HEXO, Neptune, Organigram, Charlotte's Web, and Tilray. While the content is strictly financial analysis, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024874', indicating it was part of a document production for a US House Oversight Committee investigation, likely related to broader financial inquiries.

Financial analyst report / equity research
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024873.jpg

This document is page 57 of a Cowen Collaborative Insights report dated February 25, 2019, detailing the strategies of major Canadian cannabis companies (Aphria, Aurora, Canopy Growth, Cronos, Emblem, and Emerald Health) regarding the hemp and CBD markets. It aggregates quotes from CEO earnings calls and press releases concerning market expansion into Europe and the US, as well as strategic partnerships. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely part of a document production for a congressional investigation.

Financial research report / industry commentary
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024872.jpg

This document is a page from a Cowen Collaborative Insights equity research report dated February 25, 2019. It analyzes several companies in the cannabis and tobacco sectors, including GTI, Khiron Life Sciences, Level Brands, Tilray, and Turning Point Brands, providing revenue figures, stock ratings, and acquisition details. The document bears a House Oversight Committee Bates stamp, suggesting it was included in document production for a congressional investigation, likely related to financial institutions, though the page itself contains no direct references to Jeffrey Epstein.

Financial research report / equity research
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024871.jpg

This document is page 55 of a Cowen financial research report dated February 25, 2019, analyzing the cannabis and CBD market. It details the business models, revenues, and strategies of companies including Curaleaf, CV Sciences, Elixinol, and Green Thumb Industries (Beboe). The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was likely produced as part of a congressional investigation, though no specific Epstein connection is mentioned in the text of this page.

Financial research report
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024867.jpg

A Cowen 'Collaborative Insights' financial report page dated February 25, 2019, analyzing the U.S. market for CBD vapor and e-cigarettes. The document projects significant growth in the sector, forecasting CBD vape revenues to reach $360 million by 2020 and comparing this to JUUL's market share. The page includes three figures (95, 96, 97) illustrating sales forecasts and scenario analysis, and bears a House Oversight Committee Bates stamp.

Financial research report / market analysis
2025-11-19
Analysis Source

HOUSE_OVERSIGHT_024866.jpg

A page from a Cowen Collaborative Insights market research report dated February 25, 2019, analyzing the pricing segments of CBD confections and bars. It presents data on various brands like Lord Jones and baceae, categorizing them into Super Premium, Premium, Main, and Value segments based on price per milligram of CBD. The document bears a 'HOUSE_OVERSIGHT_024866' stamp, indicating it was part of a document production for a congressional investigation.

Market research report / financial analysis
2025-11-19
Analysis Source
Total Received
$0.00
0 transactions
Total Paid
$0.00
0 transactions
Net Flow
$0.00
0 total transactions
No financial transactions found for this entity. Entity linking may need to be improved.
As Sender
0
As Recipient
28
Total
28

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report on Synthetic Biology and Cannabinoid production.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and Epidiolex efficacy/safety data.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Research report regarding GW Pharma and CBD clinical trials.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding CBD/Cannabis regulations in Europe.

Report distribution
2019-02-25
Communication Source

Consumer Products Market Sizing (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Market research report regarding CBD usage statistics and market sizing.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Financial analysis of the U.S. Beauty and CBD Beauty markets.

Report distribution
2019-02-25
Communication Source

Collaborative Insights: Vapor

From: Cowen
To: Michael Cella

Market analysis of CBD vapor and e-cigarette sales projections.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule providers distributed to michael.cella@cowen.com

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market analysis of CBD confection and bar products, including price segmentation.

Report distribution
2019-02-25
Communication Source

Valuation Methodology and Risks

From: Cowen
To: Michael Cella

Investment report distribution restricted to michael.cella@cowen.com

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights Report

From: Cowen
To: Michael Cella

Analysis of Epidiolex drug trials and investor sentiment regarding efficacy with/without clobazam.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial analysis of cannabis and tobacco companies.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights - CBD Market Analysis

From: Cowen
To: Michael Cella

Market research report regarding CBD capsule pricing and demographic usage statistics.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis of CBD gummy pricing and packaging.

Report distribution
2019-02-25
Communication Source

Report Distribution

From: Cowen
To: Michael Cella

This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.

Report distribution
2019-02-25
Communication Source

Collaborative Insights

From: Cowen
To: Michael Cella

Financial report regarding cannabis market partnerships.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry report on Synthetic Biology Cannabinoid Companies.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report regarding hemp and CBD in textiles.

Report distribution
2019-02-25
Communication Source

Collaborative Insights - Topicals

From: Cowen
To: Michael Cella

Markey analysis of CBD topicals distributed to internal employee.

Report distribution
2019-02-25
Communication Source

Global CBD Landscape (Azer)

From: Cowen Collaborative In...
To: Michael Cella

Analysis of international drug conventions and WHO recommendations regarding CBD regulation.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Industry analysis regarding CBD-infused textiles and partnerships.

Report distribution
2019-02-25
Communication Source

Collaborative Insights Report

From: Cowen
To: Michael Cella

Financial rating history charts for GW Pharmaceuticals, Tilray, and Turning Point Brands.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights Report

From: Cowen
To: Michael Cella

Market analysis report regarding Uruguayan cannabis market.

Report distribution
2019-02-25
Communication Source

Cowen Collaborative Insights

From: Cowen
To: Michael Cella

Market research report on Cannabis/CBD in Switzerland and France

Report distribution
2019-02-25
Communication Source

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein entity

Back to Search